Sébastien Morin

Well done, and very #insightful, even for someone who has used #MedsPaL weekly for multiple years!

🎥 New MedsPaL Video Series!

Continuing our mission to help users navigate the enhanced #MedsPaL platform! 🌍💊

🔍 You’ll learn how to explore #licence data efficiently and unlock valuable insights for your work!

🔗 Explore more at: www.medspal.org

Yesterday, the #AORTIC Medical Oncology Special Interest Group held a panel on Expanding #Immunotherapy #Access in Africa: Early Lessons and Cost Considerations 🌍

The discussion offered lessons for expanding equitable access to life-saving #treatments across the continent ✨

🌍 MPP is hiring!

In partnership with Ganci Partners, MPP is seeking an #ExecutiveDirector to lead our mission of delivering life-saving medicines to those who need them most.

📧 Apply by Feb 16, 2026
👉 lnkd.in/eyMVr_vj

Working tirelessly behind every licence & would-be licences !

See our in-licensing #priorities: #HIV; #HCV; #HBV; #TB; #infant #RSV #prevention; #malaria; #PPR; #CF; #cancer; #diabetes; #cardiovascular; #metabolics

lnkd.in/eSFfWKbR ! ⭐

#Equity #AccessToMedicines
#BetterMeds4Kids #GlobalHealth

#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs.

Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...

On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind.

🔗 bit.ly/3WYVNzB

Preventing a hidden killer of infants in low- and middle-income countries - MPP Respiratory syncytial virus (RSV) is the leading causes of lower respiratory tract infections and mortality among young children across the world. Estimates suggest it causes over 100,000 deaths and 3...

🦠 #RSV kills 100,000+ young children yearly, 97% in LMICs. Prevention works, but access to life-saving monoclonal antibodies is limited. On #WorldChildrensDay, let’s push for affordable RSV prevention so every child gets a healthy start. Learn more: bit.ly/4o0XGqo

MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪

Would you like to explore ways in which we could collaborate? 🤝

Get in touch: medicinespatentpool.org/licensingsav...

#Sustainability #FundingHealthEquity

MPP's Statement at the WHO Intergovernmental Working Group - MPP Question: “How could your entity contribute in a practical and sustainable manner to the Pathogen Access and Benefit Sharing System (PABS)?” Statement  We believe that Medicines Patent Pool (MPP) can ...

MPP’s work in #licensing, #techtransfer and capacity-building aligns with Article 12’s benefit-sharing goals. We’ve long partnered with @who.int and Member States to turn these principles into access. 🤝🌍

👉 medicinespatentpool.org/news-publica...

YouTube video by MedicinesPatentPool #LicensingSavesLives - Pushing the boundaries of global health access

🌍 Around the world, millions of people cannot access the medicines they need — not because the treatments don’t exist, but because they remain out of reach.

At MPP, we work to change that.

✨ Join us: lnkd.in/eDizXjQb

Watch the video: www.youtube.com/watch?v=3kqd...

#LicensingSavesLives

YouTube video by MedicinesPatentPool #LicensingSavesLives - Pushing the boundaries of global health access

MPP joins @who.int @unaids.org @unitaid.bsky.social & partners to mark #WorldAIDSDay. Expanding access to dolutegravir-based regimens, paediatric formulations & long-acting therapeutics is vital for equity & choice. Through licensing, MPP helps make this possible.
🔗 shorturl.at/gEMKd

MPP and @unitaid.bsky.social are co-hosting “Breaking New Grounds: Long-Acting HIV Treatment for a New Generation”, at #ICASA2025.

📅 Wednesday 3 December 2025 | 11:45–12:30 GMT
📍 Room Prof. Souleymane Mboup & online

Join us to discuss why long-acting HIV treatment matters.
lnkd.in/e7DTMEYc

WHO issues global guideline on the use of GLP-1 medicines in treating obesity To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for tr...

Yesterday, @who.int released its first-ever guideline on the use of GLP-1 therapies for adults living with obesity. This milestone follows the inclusion of GLP-1 medicines in the Essential Medicines List for managing type 2 diabetes in high-risk groups.

👉 www.who.int/news/item/01...

On #WorldAIDSDay, let's remember the role of #communities in driving the response, and how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍

On #WorldAIDSDay, let's remember how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍

On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines.

Learn more: www.who.int/initiatives/...

@pablorojo.bsky.social @sebmoringva.bsky.social

It was a pleasure to take part in GAP-f annual members' meeting, reviewing the tremendous #progress of our collaborative network in prioritizing #BetterMeds4Kids in 5 new therapeutic areas during 2025! -> This is what #WorldChildrensDay is about!

#SickleCellDisease #Epilepsy #RSV #Dengue #Malaria

A man hold his child in his arms.

Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍

Among 100,000 #RSV deaths/year in children, 97% are in #LMICs & half in infants <6 months. Today is #WorldChildrensDay & we are reminded about inequitable diseases disproportionately affecting our young loved ones. Let's work together & create real change! 🤍
#Equity #GlobalHealth #BetterMeds4Kids

This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍
-
#BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV

As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝

Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact.

Would you like to explore ways in which we could collaborate?
👉 medicinespatentpool.org/licensingsav...

#FundingHealthEquity #GlobalHealth

With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth!

#Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs.

#AccessToMedicines #HealthEquity

The Global Accelerator for Paediatric Formulations (GAP-f) at
@who.int & @accesstomedicinefoundation.org invite pharmaceutical innovators & manufacturers to discuss the GAP-f 2025-30 strategy & discuss medicines for childhood cancer, epilepsy, malaria, RSV -> Register at who.zoom.us/meeting/regi...

Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.

Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!

lnkd.in/eruiP-Gv

Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign.

Thank you to all colleagues for your energy, we look forward to what lies ahead!

At the UN High-Level Meeting on NCDs and Mental Health, MPP and partners convened a roundtable on expanding access to NCD medicines in LMICs.

Together, we aim to turn commitments into action for equitable, affordable access. 🌍

medicinespatentpool.org/news-publica...

MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs.

👉 medicinespatentpool.org/story-post/m...

🌍 We’re hiring!

The Medicines Patent Pool is looking for a Programme Finance Officer to join our team in Geneva, Switzerland.

📅 Apply by: 31 October 2025
📧 Send your application to: recruitment@medicinespatentpool.org

Learn more 👉 medicinespatentpool.org/call-for-app...